Pet Diabetes Care Devices Market By Device Type (Glucose monitoring devices, Insulin delivery devices), By Animal Type (Dogs, Cats), By End Users (Homecare, Veterinary hospitals, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

List of Tables

The global pet diabetes care devices market was valued at $1.9 billion in 2021, and is projected to reach $3.5 billion by 2031, growing at a CAGR of 6.3% from 2022 to 2031.

Diabetes mellitus, or diabetes, is a condition that occurs when the body cannot use glucose normally. Glucose is the main source of energy for the body's cells. Pets such as dogs, cats and also livestock suffer from diabetes too. Obesity is a significant risk factor for development of diabetes in pets, they may also develop other diseases that can result in diabetes or can significantly affect their response to treatment for diabetes, including over activity of the adrenal gland in dogs or hyperthyroidism in cats, pancreatitis, heart disease, kidney disease, urinary tract infections and skin infections. To treat this condition in pets, there are device segments available in the market that are bifurcated into glucose monitoring devices and insulin delivery devices.

The growth of the pet diabetes care devices market is driven by factors such as increase in incidence of diabetes, increase in demand for diabetes monitoring devices in the veterinary hospitals and increase in the technological advancements of the pet diabetes care devices. Moreover, increase in the adoption of pets for several benefits of the humans, rise in cases of pet obesity across the globe, favorable government support for animal type healthcare, growth in awareness about veterinary healthcare importance among the pet owners, rise in animal healthcare expenditure and increase in the number of hospitals & animal healthcare centers also helps in the growth of the market. For instance, according to the data of American Pet Products Association (APPA), in 2019, the pet expenditure reached $95.7 billion in 2019, which was a 5% increase than 2018. This outlay covers pet food, treats, over-the-counter medicine, vet care, animal type health products and other services (include boarding, grooming, insurance, training, pet sitting and walking). However, the limited awareness surrounding proper management of pet diabetes is expected to hinder the growth of this market. Conversely, increased research initiatives on pet diabetes is expected to create lucrative opportunities for the market.

The global pet diabetes care devices market is segmented on the basis of device type, animal type, end user and region. On the basis of device type, the market is bifurcated into glucose monitoring devices and insulin delivery devices. On the basis of animal type, the market is classified into dogs and cats. On the basis of end user, the market is classified into homecare, veterinary hospitals and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major companies profiled in the report include AccuBioTech Co., Ltd., Allison Medical Inc., ALR Technologies Inc., Becton, Dickinson and Company, MED Trust, Merck Animal Health, TaiDoc, UltiMed, Inc., Zoetis, i-SENS, Inc.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pet diabetes care devices market analysis from 2021 to 2031 to identify the prevailing pet diabetes care devices market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the pet diabetes care devices market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global pet diabetes care devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Animal Type

Dogs
Cats

By End Users

Homecare
Veterinary hospitals
Others

By Device Type

Glucose monitoring devices
Insulin delivery devices

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Allison Medical Inc.
- ALR Technologies Inc.
- Med Trust LLC
- Zoetis
- AccuBioTech Co., Ltd.
- Merck & Co. Inc.
- Becton, Dickinson and Company
- Taidoc Technology Corp.
- UltiMed, Inc
- I-SENS. Inc.

Product Code: A12060

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Market dynamics
- 3.4.1.Drivers
  - 3.4.1.1. Increase in the number of pet adoption.
  - 3.4.1.2. Rise in the prevalence of diabetes in pets.
  - 3.4.1.3. Rise in the pet obesity.
  - 3.4.1.4. Increase in the research and development activity related to the treatment of diabetes.
- 3.4.2.Restraints
  - 3.4.2.1. High cost of diabetic medications.
- 3.4.3.Opportunities
  - 3.4.3.1. Technological advancements in the diabetes care devices.
3.5.COVID-19 Impact Analysis on the market

CHAPTER 4: PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE

4.1 Overview
- 4.1.1 Market size and forecast
4.2. Glucose monitoring devices
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market share analysis by country
4.3. Insulin delivery devices
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market share analysis by country

CHAPTER 5: PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE

5.1 Overview
- 5.1.1 Market size and forecast
5.2. Dogs
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market share analysis by country
5.3. Cats
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market share analysis by country

CHAPTER 6: PET DIABETES CARE DEVICES MARKET, BY END USERS

6.1 Overview
- 6.1.1 Market size and forecast
6.2. Homecare
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market share analysis by country
6.3. Veterinary hospitals
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market share analysis by country
6.4. Others
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market share analysis by country

CHAPTER 7: PET DIABETES CARE DEVICES MARKET, BY REGION

7.1 Overview
- 7.1.1 Market size and forecast
7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Device Type
- 7.2.3 North America Market size and forecast, by Animal Type
- 7.2.4 North America Market size and forecast, by End Users
- 7.2.5 North America Market size and forecast, by country
  - 7.2.5.1 U.S.
  - 7.2.5.1.1 Key market trends, growth factors and opportunities
  - 7.2.5.1.2 Market size and forecast, by Device Type
  - 7.2.5.1.3 Market size and forecast, by Animal Type
  - 7.2.5.1.4 Market size and forecast, by End Users
  - 7.2.5.2 Canada
  - 7.2.5.2.1 Key market trends, growth factors and opportunities
  - 7.2.5.2.2 Market size and forecast, by Device Type
  - 7.2.5.2.3 Market size and forecast, by Animal Type
  - 7.2.5.2.4 Market size and forecast, by End Users
  - 7.2.5.3 Mexico
  - 7.2.5.3.1 Key market trends, growth factors and opportunities
  - 7.2.5.3.2 Market size and forecast, by Device Type
  - 7.2.5.3.3 Market size and forecast, by Animal Type
  - 7.2.5.3.4 Market size and forecast, by End Users
7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Device Type
- 7.3.3 Europe Market size and forecast, by Animal Type
- 7.3.4 Europe Market size and forecast, by End Users
- 7.3.5 Europe Market size and forecast, by country
  - 7.3.5.1 Germany
  - 7.3.5.1.1 Key market trends, growth factors and opportunities
  - 7.3.5.1.2 Market size and forecast, by Device Type
  - 7.3.5.1.3 Market size and forecast, by Animal Type
  - 7.3.5.1.4 Market size and forecast, by End Users
  - 7.3.5.2 France
  - 7.3.5.2.1 Key market trends, growth factors and opportunities
  - 7.3.5.2.2 Market size and forecast, by Device Type
  - 7.3.5.2.3 Market size and forecast, by Animal Type
  - 7.3.5.2.4 Market size and forecast, by End Users
  - 7.3.5.3 UK
  - 7.3.5.3.1 Key market trends, growth factors and opportunities
  - 7.3.5.3.2 Market size and forecast, by Device Type
  - 7.3.5.3.3 Market size and forecast, by Animal Type
  - 7.3.5.3.4 Market size and forecast, by End Users
  - 7.3.5.4 Italy
  - 7.3.5.4.1 Key market trends, growth factors and opportunities
  - 7.3.5.4.2 Market size and forecast, by Device Type
  - 7.3.5.4.3 Market size and forecast, by Animal Type
  - 7.3.5.4.4 Market size and forecast, by End Users
  - 7.3.5.5 Spain
  - 7.3.5.5.1 Key market trends, growth factors and opportunities
  - 7.3.5.5.2 Market size and forecast, by Device Type
  - 7.3.5.5.3 Market size and forecast, by Animal Type
  - 7.3.5.5.4 Market size and forecast, by End Users
  - 7.3.5.6 Rest of Europe
  - 7.3.5.6.1 Key market trends, growth factors and opportunities
  - 7.3.5.6.2 Market size and forecast, by Device Type
  - 7.3.5.6.3 Market size and forecast, by Animal Type
  - 7.3.5.6.4 Market size and forecast, by End Users
7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Device Type
- 7.4.3 Asia-Pacific Market size and forecast, by Animal Type
- 7.4.4 Asia-Pacific Market size and forecast, by End Users
- 7.4.5 Asia-Pacific Market size and forecast, by country
  - 7.4.5.1 China
  - 7.4.5.1.1 Key market trends, growth factors and opportunities
  - 7.4.5.1.2 Market size and forecast, by Device Type
  - 7.4.5.1.3 Market size and forecast, by Animal Type
  - 7.4.5.1.4 Market size and forecast, by End Users
  - 7.4.5.2 Japan
  - 7.4.5.2.1 Key market trends, growth factors and opportunities
  - 7.4.5.2.2 Market size and forecast, by Device Type
  - 7.4.5.2.3 Market size and forecast, by Animal Type
  - 7.4.5.2.4 Market size and forecast, by End Users
  - 7.4.5.3 India
  - 7.4.5.3.1 Key market trends, growth factors and opportunities
  - 7.4.5.3.2 Market size and forecast, by Device Type
  - 7.4.5.3.3 Market size and forecast, by Animal Type
  - 7.4.5.3.4 Market size and forecast, by End Users
  - 7.4.5.4 Australia
  - 7.4.5.4.1 Key market trends, growth factors and opportunities
  - 7.4.5.4.2 Market size and forecast, by Device Type
  - 7.4.5.4.3 Market size and forecast, by Animal Type
  - 7.4.5.4.4 Market size and forecast, by End Users
  - 7.4.5.5 South Korea
  - 7.4.5.5.1 Key market trends, growth factors and opportunities
  - 7.4.5.5.2 Market size and forecast, by Device Type
  - 7.4.5.5.3 Market size and forecast, by Animal Type
  - 7.4.5.5.4 Market size and forecast, by End Users
  - 7.4.5.6 Rest of Asia-Pacific
  - 7.4.5.6.1 Key market trends, growth factors and opportunities
  - 7.4.5.6.2 Market size and forecast, by Device Type
  - 7.4.5.6.3 Market size and forecast, by Animal Type
  - 7.4.5.6.4 Market size and forecast, by End Users
7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Device Type
- 7.5.3 LAMEA Market size and forecast, by Animal Type
- 7.5.4 LAMEA Market size and forecast, by End Users
- 7.5.5 LAMEA Market size and forecast, by country
  - 7.5.5.1 Brazil
  - 7.5.5.1.1 Key market trends, growth factors and opportunities
  - 7.5.5.1.2 Market size and forecast, by Device Type
  - 7.5.5.1.3 Market size and forecast, by Animal Type
  - 7.5.5.1.4 Market size and forecast, by End Users
  - 7.5.5.2 Saudi Arabia
  - 7.5.5.2.1 Key market trends, growth factors and opportunities
  - 7.5.5.2.2 Market size and forecast, by Device Type
  - 7.5.5.2.3 Market size and forecast, by Animal Type
  - 7.5.5.2.4 Market size and forecast, by End Users
  - 7.5.5.3 South Africa
  - 7.5.5.3.1 Key market trends, growth factors and opportunities
  - 7.5.5.3.2 Market size and forecast, by Device Type
  - 7.5.5.3.3 Market size and forecast, by Animal Type
  - 7.5.5.3.4 Market size and forecast, by End Users
  - 7.5.5.4 Rest of LAMEA
  - 7.5.5.4.1 Key market trends, growth factors and opportunities
  - 7.5.5.4.2 Market size and forecast, by Device Type
  - 7.5.5.4.3 Market size and forecast, by Animal Type
  - 7.5.5.4.4 Market size and forecast, by End Users

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

9.1 Allison Medical Inc.
- 9.1.1 Company overview
- 9.1.2 Key Executives
- 9.1.3 Company snapshot
- 9.1.4 Operating business segments
- 9.1.5 Product portfolio
- 9.1.6 Business performance
- 9.1.7 Key strategic moves and developments
9.2 ALR Technologies Inc.
- 9.2.1 Company overview
- 9.2.2 Key Executives
- 9.2.3 Company snapshot
- 9.2.4 Operating business segments
- 9.2.5 Product portfolio
- 9.2.6 Business performance
- 9.2.7 Key strategic moves and developments
9.3 Med Trust LLC
- 9.3.1 Company overview
- 9.3.2 Key Executives
- 9.3.3 Company snapshot
- 9.3.4 Operating business segments
- 9.3.5 Product portfolio
- 9.3.6 Business performance
- 9.3.7 Key strategic moves and developments
9.4 Zoetis
- 9.4.1 Company overview
- 9.4.2 Key Executives
- 9.4.3 Company snapshot
- 9.4.4 Operating business segments
- 9.4.5 Product portfolio
- 9.4.6 Business performance
- 9.4.7 Key strategic moves and developments
9.5 AccuBioTech Co., Ltd.
- 9.5.1 Company overview
- 9.5.2 Key Executives
- 9.5.3 Company snapshot
- 9.5.4 Operating business segments
- 9.5.5 Product portfolio
- 9.5.6 Business performance
- 9.5.7 Key strategic moves and developments
9.6 Merck & Co. Inc.
- 9.6.1 Company overview
- 9.6.2 Key Executives
- 9.6.3 Company snapshot
- 9.6.4 Operating business segments
- 9.6.5 Product portfolio
- 9.6.6 Business performance
- 9.6.7 Key strategic moves and developments
9.7 Becton, Dickinson and Company
- 9.7.1 Company overview
- 9.7.2 Key Executives
- 9.7.3 Company snapshot
- 9.7.4 Operating business segments
- 9.7.5 Product portfolio
- 9.7.6 Business performance
- 9.7.7 Key strategic moves and developments
9.8 Taidoc Technology Corp.
- 9.8.1 Company overview
- 9.8.2 Key Executives
- 9.8.3 Company snapshot
- 9.8.4 Operating business segments
- 9.8.5 Product portfolio
- 9.8.6 Business performance
- 9.8.7 Key strategic moves and developments
9.9 UltiMed, Inc
- 9.9.1 Company overview
- 9.9.2 Key Executives
- 9.9.3 Company snapshot
- 9.9.4 Operating business segments
- 9.9.5 Product portfolio
- 9.9.6 Business performance
- 9.9.7 Key strategic moves and developments
9.10 I-SENS. Inc.
- 9.10.1 Company overview
- 9.10.2 Key Executives
- 9.10.3 Company snapshot
- 9.10.4 Operating business segments
- 9.10.5 Product portfolio
- 9.10.6 Business performance
- 9.10.7 Key strategic moves and developments